Jobs at Pathos AI

Recomputed daily from public data: capital freshness (0-35) + hiring velocity (0-30) + pay transparency (0-20) + employer rating (0-15; unrated scores the neutral 7), minus up to 10 for documented headwinds (lawsuits, layoffs, leadership churn). Transparent formula, not investment or career advice.

In the news

Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pact Fierce Biotech · 2026-08-04

Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic Business Wire · 2026-08-03

Exclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation Endpoints News · 2026-08-03

Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents MedCity News · 2026-08-04

Auto-pulled from Google News, refreshed daily; headlines belong to their publishers

Momentum index 22/100 = capital freshness (0-35) + hiring velocity (0-30) + comp transparency (0-20) + workplace rating (0-15), minus documented headwinds. Recomputed daily; not investment or career advice.